Next Article in Journal
The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma
Previous Article in Journal
SELENOF Controls Proliferation and Cell Death in Breast-Derived Immortalized and Cancer Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 15
Issue 14
10.3390/cancers15143668
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Expression of Concern: Cancers 2022, 14(19), 4774.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Expression of Concern

Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774

by
Cancers Editorial Office
MDPI, St. Alban-Anlage 66, 4052 Basel, Switzerland
Cancers 2023, 15(14), 3668; https://doi.org/10.3390/cancers15143668
Submission received: 29 June 2023 / Accepted: 17 July 2023 / Published: 19 July 2023
Versions Notes
The Cancers Editorial Office is issuing this expression of concern to alert readers to concerns regarding the findings of the published manuscript [1]. As the publication could influence patient treatment, the Cancers Editorial Office has decided to issue an expression of concern for the duration of the investigation.
The Expression of Concern will remain until a resolution has been reached.
We will provide an update following the conclusion of the investigation. The author has been notified about this Expression of Concern. In order to maintain the highest scientific standards, an in-depth investigation has been initiated by the responsible editors, together with the journal’s editorial office, in collaboration with the editorial board, and in accordance with the Committee on Publication Ethics (COPE) guidance.

Reference

  1. Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cancers Editorial Office. Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774. Cancers 2023, 15, 3668. https://doi.org/10.3390/cancers15143668

AMA Style

Cancers Editorial Office. Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774. Cancers. 2023; 15(14):3668. https://doi.org/10.3390/cancers15143668

Chicago/Turabian Style

Cancers Editorial Office. 2023. "Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774" Cancers 15, no. 14: 3668. https://doi.org/10.3390/cancers15143668

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop